Visceral Pain Treatment Market, by Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), by Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable

Visceral Pain Treatment Market, by Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), by Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable Bowel Syndrome), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Visceral pain is defined as the pain that results from the nociceptors activation of the pelvic, thoracic or abdominal bowels (organs). The visceral structures are highly sensitive to stretch (distension), inflammation, and ischemia, but moderately insensitive to other stimuli that usually evoke pain such as burning or cutting. The symptoms of visceral pain are vomiting, nausea, changes in vital signs, and emotional manifestations. Pregabalin or gabapentin are some of the medications used for visceral pain treatment.
Market Dynamics
The ongoing research and development by pharmaceutical companies and increasing investments by many governments are expected to propel the visceral pain treatment market growth over the forecast period. For instance, in February 2020, DNDi (Drugs for Neglected Types initiative) and Novartis entered into a joint license agreement to co-develop a potential new treatment for visceral leishmaniasis. Furthermore, the rising prevalence of irritable bowel syndrome (IBS) across the globe is likely to drive the market growth. For instance, in 2016, according to the IFFGD (International Foundation for Gastrointestinal Disorders), around 10 to 15 per cent of the adult population across the globe are affected by IBS each year.
Moreover, key players in this market are highly investing in research and development to develop, create, and commercialize novel drugs for visceral pain, which will create growth opportunities in the global visceral pain treatment market over the forecast period. However, the lack of specific treatment for visceral pain such as Crohn’s disease and irritable bowel syndrome is expected to restrict the market growth in the near future.
Key features of the study:
This report provides in-depth analysis of the global visceral pain treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global visceral pain treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study are Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global visceral pain treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for visceral pain treatment market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
Global Visceral Pain Treatment Market, By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
Global Visceral Pain Treatment Market, By Indication:
Irritable bowel syndrome
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
Global Visceral Pain Treatment Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Global Visceral Pain Treatment Market, By Region:
North America
By Country:
U.S.
Canada
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels
Africa
By Country/Region:
South Africa
North Africa
Central Africa
By Drug Type:
Pain modifiers
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
Narcotics
NSAID
Others
By Indication:
Irritable bowel
Chronic prostatitis
Interstitial cystitis
Crohn’s Disease
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Channels